Ironwood Pharmaceuticals Inc
IRWD· Nasdaq
Released May 4, 2023, before the open
10-Q filed May 4, 2023, 34 days after period end · 0001558370-23-008092
| Metric | Q1 2023 | Q1 2021 | Q1 2019 | Q1 2018 |
|---|---|---|---|---|
| Revenue | $104.06M | $104.03M | $68.73M | $69.16M |
| Net Income | $45.71M | $391.30M | -$59.28M | -$43.14M |
| EPS Diluted |
Ironwood Pharmaceuticals Inc · CIK 1446847 · Engraved from SEC EDGAR
| $0.25 |
| $2.39 |
| -$0.38 |
| -$0.29 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.